Vitality Watch

Dossier clinicaltrials trial early 28-jul-2026
Small or early-phase human trial or pilot study

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease

Key claim: Investigators hypothesize that Ketosteril added to a low-protein diet can improve sarcopenia in CKD stage 3–4 patients without worsening renal function.

Abstract

The investigators hypothesize that Ketosteril can improve sarcopenia in patients with renal disease without increasing the burden on the kidneys and causing deterioration of renal function. Therefore, this study intends to take patients with CKD stage 3-4 and sarcopenia as the research object, give Ketosteril intervention or not to patients on the base of low-protein diet, and clarify the clinical benefits of Ketosteril prescription for improving sarcopenia in patients with CKD.

Why this matters

Investigators hypothesize that Ketosteril added to a low-protein diet can improve sarcopenia in CKD stage 3–4 patients without worsening renal function.

Source

Link

Briefing card

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease
Stage: trial early · clinicaltrials · 28-jul-2026

Investigators hypothesize that Ketosteril added to a low-protein diet can improve sarcopenia in CKD stage 3–4 patients without worsening renal function.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06329622

build build 880 · 2bcef25 · 2026-11-18